{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:32:10Z","timestamp":1777901530364,"version":"3.51.4"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Seed Foundation of Zhejiang Provincial People\u2019s Hospital","award":["ZRY2022J007"],"award-info":[{"award-number":["ZRY2022J007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302918"],"award-info":[{"award-number":["82302918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang province","doi-asserted-by":"crossref","award":["2024KY758"],"award-info":[{"award-number":["2024KY758"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang province","doi-asserted-by":"crossref","award":["2025HY0772"],"award-info":[{"award-number":["2025HY0772"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang province","doi-asserted-by":"crossref","award":["2025HY0770"],"award-info":[{"award-number":["2025HY0770"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LQ24H160044"],"award-info":[{"award-number":["LQ24H160044"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["QN26H160024"],"award-info":[{"award-number":["QN26H160024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2024WJC187"],"award-info":[{"award-number":["2024WJC187"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2022WJC232"],"award-info":[{"award-number":["2022WJC232"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2024WJC072"],"award-info":[{"award-number":["2024WJC072"]}]},{"name":"Zhejiang Province Traditional Chinese Medicine Science and Technology Project","award":["2026ZL0638"],"award-info":[{"award-number":["2026ZL0638"]}]},{"name":"Hangzhou Joint Fund of Zhejiang Provincial Natural Science Foundation of China","award":["LHZQN26H160006"],"award-info":[{"award-number":["LHZQN26H160006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10495-026-02330-1","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:27:44Z","timestamp":1774776464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Programmed cell death: a promising management for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Qianqian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruonan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renhao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"20","key":"2330_CR1","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.1039\/D5CS00544B","volume":"54","author":"C Dey","year":"2025","unstructured":"Dey C, Roy M, Pal P, Ghosh R, Dey SG (2025) Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Abeta relevant to Alzheimer\u2019s disease. Chem Soc Rev 54(20):9457\u20139499","journal-title":"Chem Soc Rev"},{"issue":"5","key":"2330_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D (2024) A guide to cell death pathways. Nat Rev Mol Cell Biol 25(5):379\u2013395","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2330_CR3","doi-asserted-by":"publisher","first-page":"102575","DOI":"10.1016\/j.arr.2024.102575","volume":"102","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Anwar S, Venkatesan K, Shahwan M, Hassan MI, Islam A et al (2024) Iron homeostasis and neurodegeneration in the ageing brain: insight into ferroptosis pathways. Ageing Res Rev 102:102575","journal-title":"Ageing Res Rev"},{"issue":"11","key":"2330_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinsztein DC (2024) Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol 25(11):926\u2013946","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2330_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","volume":"147","author":"S Balusu","year":"2024","unstructured":"Balusu S, De Strooper B (2024) The necroptosis cell death pathway drives neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 147(1):96","journal-title":"Acta Neuropathol"},{"key":"2330_CR6","doi-asserted-by":"publisher","first-page":"102599","DOI":"10.1016\/j.arr.2024.102599","volume":"104","author":"HK Krishnamurthy","year":"2025","unstructured":"Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C et al (2025) An overview of the genes and biomarkers in Alzheimer\u2019s disease. Ageing Res Rev 104:102599","journal-title":"Ageing Res Rev"},{"key":"2330_CR7","unstructured":"Li H, Wang W, Zhang L, Wang T, Liu J, Wu J et al (2025) Inflammatory bridges: interconnections between Alzheimer\u2019s disease and bone health. Aging Dis"},{"key":"2330_CR8","doi-asserted-by":"crossref","unstructured":"Twarowski B, Herbet M (2023) Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: a review. Int J Mol Sci. 24(7)","DOI":"10.3390\/ijms24076518"},{"issue":"6","key":"2330_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S1474-4422(25)00116-4","volume":"24","author":"C Marino","year":"2025","unstructured":"Marino C, Malotaux V, Giudicessi A, Aguillon D, Sepulveda-Falla D, Lopera F et al (2025) Protective genetic variants against Alzheimer\u2019s disease. Lancet Neurol 24(6):524\u2013534","journal-title":"Lancet Neurol"},{"issue":"1","key":"2330_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9(1):211","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2330_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68\u201380","journal-title":"Lancet Neurol"},{"issue":"8","key":"2330_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","volume":"20","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Hyman BT, Serrano-Pozo A (2024) Multifaceted roles of APOE in Alzheimer disease. Nat Rev Neurol 20(8):457\u2013474","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"2330_CR13","doi-asserted-by":"publisher","first-page":"113310","DOI":"10.1016\/j.celrep.2023.113310","volume":"42","author":"T Vanova","year":"2023","unstructured":"Vanova T, Sedmik J, Raska J, Amruz Cerna K, Taus P, Pospisilova V et al (2023) Cerebral organoids derived from patients with Alzheimer\u2019s disease with PSEN1\/2 mutations have defective tissue patterning and altered development. Cell Rep 42(11):113310","journal-title":"Cell Rep"},{"issue":"2","key":"2330_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X (2025) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16(2):83\u2013120","journal-title":"Protein Cell"},{"key":"2330_CR15","doi-asserted-by":"crossref","unstructured":"Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C et al (2019) Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement. Biomolecules. 10(1)","DOI":"10.3390\/biom10010040"},{"key":"2330_CR16","doi-asserted-by":"crossref","unstructured":"Beata BK, Wojciech J, Johannes K, Piotr L, Barbara M (2023) Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment. Int J Mol Sci. ;24(2)","DOI":"10.3390\/ijms24021059"},{"key":"2330_CR17","doi-asserted-by":"publisher","first-page":"101960","DOI":"10.1016\/j.arr.2023.101960","volume":"88","author":"S Thakral","year":"2023","unstructured":"Thakral S, Yadav A, Singh V, Kumar M, Kumar P, Narang R et al (2023) Alzheimer\u2019s disease: molecular aspects and treatment opportunities using herbal drugs. Ageing Res Rev 88:101960","journal-title":"Ageing Res Rev"},{"issue":"9","key":"2330_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault J, Brum WS, Trudel L, Macedo AC, Bitencourt FV, Martins-Pfeifer CC et al (2025) Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 24(9):740\u2013752","journal-title":"Lancet Neurol"},{"issue":"5","key":"2330_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D et al (2025) Neuroinflammation in Alzheimer disease. Nat Rev Immunol 25(5):321\u2013352","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2330_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/0115680266259174231006070637","volume":"24","author":"FT Hakem","year":"2024","unstructured":"Hakem FT, Fouad YF, Arafa RK (2024) Gamma secretase as an important drug target for management of Alzheimer\u2019s disease: a comprehensive review. Curr Top Med Chem 24(2):109\u2013127","journal-title":"Curr Top Med Chem"},{"issue":"Pt 2","key":"2330_CR21","doi-asserted-by":"publisher","first-page":"108685","DOI":"10.1016\/j.compbiolchem.2025.108685","volume":"120","author":"S Gambhir","year":"2026","unstructured":"Gambhir S, Singh M (2026) Advancing Alzheimer\u2019s therapeutics via in silico strategies: tideglusib based multi-target analogues. Comput Biol Chem 120(Pt 2):108685","journal-title":"Comput Biol Chem"},{"issue":"4","key":"2330_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.14283\/jpad.2022.63","volume":"9","author":"CM Wischik","year":"2022","unstructured":"Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO (2022) Oral tau aggregation inhibitor for Alzheimer\u2019s disease: design, progress and basis for selection of the 16\u00a0mg\/day dose in a Phase 3, randomized, placebo-controlled trial of hydromethylthionine mesylate. J Prev Alzheimers Dis 9(4):780\u2013790","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"2330_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/nmt-2021-0022","volume":"11","author":"CL Reading","year":"2021","unstructured":"Reading CL, Ahlem CN, Murphy MF (2021) NM101 Phase III study of NE3107 in Alzheimer\u2019s disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance. Neurodegener Dis Manag 11(4):289\u2013298","journal-title":"Neurodegener Dis Manag"},{"issue":"8","key":"2330_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/13543784.2022.2095261","volume":"31","author":"M Lozupone","year":"2022","unstructured":"Lozupone M, Berardino G, Mollica A, Sardone R, Dibello V, Zupo R et al (2022) ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer\u2019s disease. Expert Opin Investig Drugs 31(8):759\u2013771","journal-title":"Expert Opin Investig Drugs"},{"issue":"7","key":"2330_CR25","doi-asserted-by":"publisher","first-page":"e011584","DOI":"10.1136\/bmjopen-2016-011584","volume":"6","author":"O Meulenbroek","year":"2016","unstructured":"Meulenbroek O, O\u2019Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F et al (2016) European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer\u2019s disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow. BMJ Open 6(7):e011584","journal-title":"BMJ Open"},{"issue":"12","key":"2330_CR26","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"389","author":"RA Sperling","year":"2023","unstructured":"Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL et al (2023) Trial of solanezumab in preclinical Alzheimer\u2019s disease. N Engl J Med 389(12):1096\u20131107","journal-title":"N Engl J Med"},{"issue":"6","key":"2330_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","volume":"1","author":"P Novak","year":"2021","unstructured":"Novak P, Kovacech B, Katina S, Schmidt R, Scheltens P, Kontsekova E et al (2021) ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer\u2019s disease. Nat Aging 1(6):521\u2013534","journal-title":"Nat Aging"},{"issue":"3","key":"2330_CR28","doi-asserted-by":"publisher","first-page":"e12498","DOI":"10.1002\/trc2.12498","volume":"10","author":"S Abushakra","year":"2024","unstructured":"Abushakra S, Porsteinsson AP, Sabbagh M, Watson D, Power A, Liang E et al (2024) APOLLOE4 Phase 3 study of oral ALZ-801\/valiltramiprosate in APOE epsilon4\/epsilon4 homozygotes with early Alzheimer\u2019s disease: trial design and baseline characteristics. Alzheimers Dement (N Y) 10(3):e12498","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"2330_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13195-021-00882-9","volume":"13","author":"EGB Vijverberg","year":"2021","unstructured":"Vijverberg EGB, Axelsen TM, Bihlet AR, Henriksen K, Weber F, Fuchs K et al (2021) Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD. Alzheimers Res Ther 13(1):142","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2330_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, Lopez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S et al (2023) Masitinib for mild-to-moderate Alzheimer\u2019s disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther 15(1):39","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2330_CR31","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1002\/alz.70068","volume":"21","author":"V Planche","year":"2025","unstructured":"Planche V, Schindler S, Knopman DS, Frisoni G, Galasko D, Grill JD et al (2025) The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer\u2019s disease based solely on biomarker evidence. Alzheimers Dement 21(4):e70068","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2330_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","volume":"8","author":"M Roberts","year":"2020","unstructured":"Roberts M, Sevastou I, Imaizumi Y, Mistry K, Talma S, Dey M et al (2020) Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):13","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2330_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B et al (2024) Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):235","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"2330_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X (2025) Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol 26(7):501\u2013521","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2330_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","volume":"24","author":"J Fu","year":"2024","unstructured":"Fu J, Schroder K, Wu H (2024) Mechanistic insights from inflammasome structures. Nat Rev Immunol 24(7):518\u2013535","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2330_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M (2024) Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov 23(1):43\u201366","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2330_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF et al (2023) Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol 145(2):175\u2013195","journal-title":"Acta Neuropathol"},{"key":"2330_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2025.03.009","volume":"573","author":"Y Li","year":"2025","unstructured":"Li Y, Yang C, Liu X, Shu J, Zhao N, Sun Z et al (2025) Potential therapeutic targets for Alzheimer\u2019s disease: fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy. Neuroscience 573:42\u201351","journal-title":"Neuroscience"},{"issue":"1","key":"2330_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12974-025-03501-8","volume":"22","author":"V Brezani","year":"2025","unstructured":"Brezani V, Joshi RS, Ortega-Ribera M, Nagesh PT, Brezani V, Zivny A et al (2025) Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer\u2019s disease associated with inflammasome activation and ASC speck propagation. J Neuroinflammation 22(1):183","journal-title":"J Neuroinflammation"},{"key":"2330_CR40","doi-asserted-by":"publisher","first-page":"102883","DOI":"10.1016\/j.arr.2025.102883","volume":"112","author":"S Kumari","year":"2025","unstructured":"Kumari S, Dhapola R, Sharma P, Paidlewar M, Vellingiri B, Medhi B et al (2025) Unravelling neuronal death mechanisms: the role of cytokines and chemokines in immune imbalance in Alzheimer\u2019s disease progression. Ageing Res Rev 112:102883","journal-title":"Ageing Res Rev"},{"key":"2330_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.11.004","volume":"536","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo S, Hu D, Dong X, Meng Z, Jiang Y et al (2024) Enhanced Gasdermin-E-mediated pyroptosis in Alzheimer\u2019s disease. Neuroscience 536:1\u201311","journal-title":"Neuroscience"},{"key":"2330_CR42","doi-asserted-by":"publisher","first-page":"872471","DOI":"10.3389\/fnmol.2022.872471","volume":"15","author":"W Xue","year":"2022","unstructured":"Xue W, Cui D, Qiu Y (2022) Research progress of pyroptosis in Alzheimer\u2019s disease. Front Mol Neurosci 15:872471","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"2330_CR43","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2174\/0929867324666170407123522","volume":"25","author":"R Mastrocola","year":"2018","unstructured":"Mastrocola R, Aragno M, Alloatti G, Collino M, Penna C, Pagliaro P (2018) Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform in metabolic syndrome. Curr Med Chem 25(11):1294\u20131310","journal-title":"Curr Med Chem"},{"issue":"8","key":"2330_CR44","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/cbf.70025","volume":"42","author":"S Suganya","year":"2024","unstructured":"Suganya S, Ashok BS, Ajith TA (2024) A recent update on the role of estrogen and progesterone in Alzheimer\u2019s disease. Cell Biochem Funct 42(8):e70025","journal-title":"Cell Biochem Funct"},{"key":"2330_CR45","doi-asserted-by":"publisher","first-page":"106263","DOI":"10.1016\/j.intimp.2020.106263","volume":"81","author":"S Yan","year":"2020","unstructured":"Yan S, Xuan Z, Yang M, Wang C, Tao T, Wang Q et al (2020) CSB6B prevents beta-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-kappaB and NLRP3 in microglia cells. Int Immunopharmacol 81:106263","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2330_CR46","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2018","unstructured":"Yin J, Zhao F, Chojnacki JE, Fulp J, Klein WL, Zhang S et al (2018) NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 55(3):1977\u20131987","journal-title":"Mol Neurobiol"},{"issue":"8","key":"2330_CR47","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1089\/dna.2018.4308","volume":"38","author":"L Feng","year":"2019","unstructured":"Feng L, Zhang L (2019) Resveratrol suppresses Abeta-induced microglial activation through the TXNIP\/TRX\/NLRP3 signaling pathway. DNA Cell Biol 38(8):874\u2013879","journal-title":"DNA Cell Biol"},{"issue":"4","key":"2330_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/cns.12066","volume":"19","author":"JQ Shi","year":"2013","unstructured":"Shi JQ, Zhang CC, Sun XL, Cheng XX, Wang JB, Zhang YD et al (2013) Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe\/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation. CNS Neurosci Ther 19(4):262\u2013268","journal-title":"CNS Neurosci Ther"},{"key":"2330_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2015.01.011","volume":"46","author":"X Liu","year":"2015","unstructured":"Liu X, Hao W, Qin Y, Decker Y, Wang X, Burkart M et al (2015) Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer\u2019s disease. Brain Behav Immun 46:121\u2013131","journal-title":"Brain Behav Immun"},{"key":"2330_CR50","doi-asserted-by":"publisher","first-page":"106943","DOI":"10.1016\/j.intimp.2020.106943","volume":"88","author":"HT Bian","year":"2020","unstructured":"Bian HT, Wang GH, Huang JJ, Liang L, Xiao L, Wang HL (2020) Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats. Int Immunopharmacol 88:106943","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"2330_CR51","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/ars.2017.7440","volume":"30","author":"CY Wang","year":"2019","unstructured":"Wang CY, Xu Y, Wang X, Guo C, Wang T, Wang ZY (2019) Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer\u2019s-Like Pathology via Nrf2-TXNIP-TrX Axis. Antioxid Redox Signal 30(11):1411\u20131431","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"2330_CR52","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1021\/acsomega.8b00841","volume":"3","author":"SS Bharate","year":"2018","unstructured":"Bharate SS, Kumar V, Singh G, Singh A, Gupta M, Singh D et al (2018) Preclinical development of Crocus sativus-based botanical lead IIIM-141 for Alzheimer\u2019s disease: chemical standardization, efficacy, formulation development, pharmacokinetics, and safety pharmacology. ACS Omega 3(8):9572\u20139585","journal-title":"ACS Omega"},{"key":"2330_CR53","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","volume":"13","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chai Y, Fu Y, Wang Y, Zhang Y, Zhang X et al (2021) Salidroside ameliorates Alzheimer\u2019s disease by targeting NLRP3 inflammasome-mediated pyroptosis. Front Aging Neurosci 13:809433","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2330_CR54","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1096\/fj.201601071R","volume":"31","author":"Q Liu","year":"2017","unstructured":"Liu Q, Chen Y, Shen C, Xiao Y, Wang Y, Liu Z et al (2017) Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis via inhibition of NF-kappaB. FASEB J 31(4):1494\u20131507","journal-title":"FASEB J"},{"issue":"5","key":"2330_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.31083\/j.jin2205129","volume":"22","author":"Y Ju","year":"2023","unstructured":"Ju Y, Zhao L, Li S, Zhao Q (2023) The role of pyroptosis in Alzheimer\u2019s disease. J Integr Neurosci 22(5):129","journal-title":"J Integr Neurosci"},{"issue":"5","key":"2330_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41581-022-00658-w","volume":"19","author":"B Kolbrink","year":"2023","unstructured":"Kolbrink B, von Samson-Himmelstjerna FA, Murphy JM, Krautwald S (2023) Role of necroptosis in kidney health and disease. Nat Rev Nephrol 19(5):300\u2013314","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2330_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J (2024) Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer 24(5):299\u2013315","journal-title":"Nat Rev Cancer"},{"key":"2330_CR58","doi-asserted-by":"publisher","first-page":"113203","DOI":"10.1016\/j.biopha.2022.113203","volume":"152","author":"R Richard","year":"2022","unstructured":"Richard R, Mousa S (2022) Necroptosis in Alzheimer\u2019s disease: potential therapeutic target. Biomed Pharmacother 152:113203","journal-title":"Biomed Pharmacother"},{"issue":"771","key":"2330_CR59","doi-asserted-by":"publisher","first-page":"eadf5128","DOI":"10.1126\/scitranslmed.adf5128","volume":"16","author":"MJ Koper","year":"2024","unstructured":"Koper MJ, Moonen S, Ronisz A, Ospitalieri S, Callaerts-Vegh Z, T\u2019Syen D et al (2024) Inhibition of an Alzheimer\u2019s disease-associated form of necroptosis rescues neuronal death in mouse models. Sci Transl Med 16(771):eadf5128","journal-title":"Sci Transl Med"},{"key":"2330_CR60","doi-asserted-by":"publisher","first-page":"115656","DOI":"10.1016\/j.biopha.2023.115656","volume":"168","author":"S Chavoshinezhad","year":"2023","unstructured":"Chavoshinezhad S, Beirami E, Izadpanah E, Feligioni M, Hassanzadeh K (2023) Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer\u2019s disease. Biomed Pharmacother 168:115656","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2330_CR61","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1021\/acschemneuro.2c00172","volume":"13","author":"W Zhao","year":"2022","unstructured":"Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J et al (2022) Targeting necroptosis as a promising therapy for Alzheimer\u2019s disease. ACS Chem Neurosci 13(12):1697\u20131713","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"2330_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/ADR-230092","volume":"8","author":"J Yeerlan","year":"2024","unstructured":"Yeerlan J, He B, Hu X, Zhang L (2024) Global research trends and hotspots for ferroptosis, necroptosis, and pyroptosis in Alzheimer\u2019s disease from the past to 2023: a combined bibliometric review. J Alzheimers Dis Rep 8(1):129\u2013142","journal-title":"J Alzheimers Dis Rep"},{"key":"2330_CR63","doi-asserted-by":"crossref","unstructured":"Kaltschmidt B, Czaniera NJ, Schulten W, Kaltschmidt C (2024) NF-kappaB in Alzheimer\u2019s disease: Friend or foe? Opposite functions in neurons and glial cells. Int J Mol Sci. 25(21)","DOI":"10.3390\/ijms252111353"},{"issue":"1","key":"2330_CR64","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-022-02567-y","volume":"19","author":"Y Dong","year":"2022","unstructured":"Dong Y, Yu H, Li X, Bian K, Zheng Y, Dai M et al (2022) Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer\u2019s disease. J Neuroinflammation 19(1):205","journal-title":"J Neuroinflammation"},{"issue":"7","key":"2330_CR65","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044","journal-title":"Cell Death Differ"},{"key":"2330_CR66","doi-asserted-by":"publisher","first-page":"1499871","DOI":"10.3389\/fnagi.2025.1499871","volume":"17","author":"D Lu","year":"2025","unstructured":"Lu D, Zhang W, Li R, Tan S, Zhang Y (2025) Targeting necroptosis in Alzheimer\u2019s disease: Can exercise modulate neuronal death? Front Aging Neurosci 17:1499871","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2330_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-022-01332-9","volume":"10","author":"N Salvadores","year":"2022","unstructured":"Salvadores N, Moreno-Gonzalez I, Gamez N, Quiroz G, Vegas-Gomez L, Escandon M et al (2022) Abeta oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer\u2019s disease. Acta Neuropathol Commun 10(1):31","journal-title":"Acta Neuropathol Commun"},{"key":"2330_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuro.2022.11.003","volume":"94","author":"S Naderi","year":"2023","unstructured":"Naderi S, Khodagholi F, Pourbadie HG, Naderi N, Rafiei S, Janahmadi M et al (2023) Role of amyloid beta (25\u201335) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer\u2019s disease. Neurotoxicology 94:71\u201386","journal-title":"Neurotoxicology"},{"issue":"1","key":"2330_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15252\/emmm.201606566","volume":"9","author":"SH Yang","year":"2017","unstructured":"Yang SH, Lee DK, Shin J, Lee S, Baek S, Kim J et al (2017) Nec-1 alleviates cognitive impairment with reduction of Abeta and tau abnormalities in APP\/PS1 mice. EMBO Mol Med 9(1):61\u201377","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2330_CR70","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cpt.1615","volume":"107","author":"HW Grievink","year":"2020","unstructured":"Grievink HW, Heuberger J, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR et al (2020) DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized Phase I ascending dose study in healthy volunteers. Clin Pharmacol Ther 107(2):406\u2013414","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2330_CR71","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"M Vissers","year":"2022","unstructured":"Vissers M, Heuberger J, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S et al (2022) Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin Transl Sci 15(8):2010\u20132023","journal-title":"Clin Transl Sci"},{"issue":"1","key":"2330_CR72","doi-asserted-by":"publisher","first-page":"e13690","DOI":"10.1111\/cts.13690","volume":"17","author":"A Hincelin-Mery","year":"2024","unstructured":"Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M et al (2024) Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci 17(1):e13690","journal-title":"Clin Transl Sci"},{"issue":"3","key":"2330_CR73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-023-05660-z","volume":"14","author":"Z Huang","year":"2023","unstructured":"Huang Z, Liang J, Chen S, Ng TK, Brelen ME, Liu Q et al (2023) RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy. Cell Death Dis 14(3):227","journal-title":"Cell Death Dis"},{"issue":"1","key":"2330_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/eji.1830160121","volume":"16","author":"Y Ishida","year":"1986","unstructured":"Ishida Y, Sekigawa I, Hamaoki M, Takenouchi T, Yumura W, Sato H et al (1986) T cells bearing unique membrane antigen and their regulatory role in humoral immune response in mice. Eur J Immunol 16(1):109\u2013112","journal-title":"Eur J Immunol"},{"key":"2330_CR75","doi-asserted-by":"publisher","first-page":"156327","DOI":"10.1016\/j.phymed.2024.156327","volume":"136","author":"VTT Nguyen","year":"2025","unstructured":"Nguyen VTT, Slotos RS, Guilherme MDS, Nguyen TT, Weisenburger S, Lehner MD et al (2025) Ginkgo biloba extract EGb 761(R) ameliorates cognitive impairment and alleviates TNFalpha response in 5xFAD Alzheimer\u2019s disease model mice. Phytomedicine 136:156327","journal-title":"Phytomedicine"},{"key":"2330_CR76","doi-asserted-by":"publisher","first-page":"9920962","DOI":"10.1155\/2021\/9920962","volume":"2021","author":"D Ma","year":"2021","unstructured":"Ma D, Li Y, Zhu Y, Wei W, Zhang L, Li Y et al (2021) Cornel iridoid glycoside ameliorated Alzheimer\u2019s disease-like pathologies and necroptosis through RIPK1\/MLKL pathway in young and aged SAMP8 mice. Evid Based Complement Alternat Med 2021:9920962","journal-title":"Evid Based Complement Alternat Med"},{"key":"2330_CR77","doi-asserted-by":"publisher","first-page":"114606","DOI":"10.1016\/j.jep.2021.114606","volume":"282","author":"XX Li","year":"2022","unstructured":"Li XX, Lang XY, Ren TT, Wang J, Lan R, Qin XY (2022) Coeloglossum viride var. bracteatum extract attenuates Abeta-induced toxicity by inhibiting RIP1-driven inflammation and necroptosis. J Ethnopharmacol 282:114606","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"2330_CR78","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41579-023-00995-y","volume":"22","author":"A Jassey","year":"2024","unstructured":"Jassey A, Jackson WT (2024) Viruses and autophagy: bend, but don\u2019t break. Nat Rev Microbiol 22(5):309\u2013321","journal-title":"Nat Rev Microbiol"},{"issue":"19","key":"2330_CR79","doi-asserted-by":"publisher","first-page":"e108863","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P et al (2021) Autophagy in major human diseases. EMBO J 40(19):e108863","journal-title":"EMBO J"},{"issue":"1","key":"2330_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14283\/jpad.2023.3","volume":"10","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H et al (2023) Programmed death of microglia in Alzheimer\u2019s disease: autophagy, ferroptosis, and pyroptosis. J Prev Alzheimers Dis 10(1):95\u2013103","journal-title":"J Prev Alzheimers Dis"},{"key":"2330_CR81","doi-asserted-by":"publisher","first-page":"1490275","DOI":"10.3389\/fmolb.2024.1490275","volume":"11","author":"ASF Mancano","year":"2024","unstructured":"Mancano ASF, Pina JG, Froes BR, Sciani JM (2024) Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer\u2019s disease. Front Mol Biosci 11:1490275","journal-title":"Front Mol Biosci"},{"key":"2330_CR82","doi-asserted-by":"publisher","first-page":"114473","DOI":"10.1016\/j.biopha.2023.114473","volume":"161","author":"X Wang","year":"2023","unstructured":"Wang X, Jia J (2023) Magnolol improves Alzheimer\u2019s disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK\/mTOR\/ULK1 pathway. Biomed Pharmacother 161:114473","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2330_CR83","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.apsb.2022.01.017","volume":"12","author":"C Yang","year":"2022","unstructured":"Yang C, Su C, Iyaswamy A, Krishnamoorthi SK, Zhu Z, Yang S et al (2022) Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: implications for Alzheimer\u2019s disease therapy. Acta Pharm Sin B 12(4):1707\u20131722","journal-title":"Acta Pharm Sin B"},{"key":"2330_CR84","doi-asserted-by":"publisher","first-page":"154711","DOI":"10.1016\/j.phymed.2023.154711","volume":"112","author":"ZS Xie","year":"2023","unstructured":"Xie ZS, Zhao JP, Wu LM, Chu S, Cui ZH, Sun YR et al (2023) Hederagenin improves Alzheimer\u2019s disease through PPARalpha\/TFEB-mediated autophagy. Phytomedicine 112:154711","journal-title":"Phytomedicine"},{"issue":"1","key":"2330_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-025-07611-2","volume":"16","author":"A Mattioni","year":"2025","unstructured":"Mattioni A, Carsetti C, Bruqi K, Caputo V, Cianfanelli V, Bacalini MG et al (2025) A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer\u2019s disease. Cell Death Dis 16(1):300","journal-title":"Cell Death Dis"},{"issue":"1","key":"2330_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-022-02521-5","volume":"145","author":"JL Hwang","year":"2023","unstructured":"Hwang JL, Perloff OS, Gaus SE, Benitez C, Alquezar C, Cosme CQ et al (2023) Tuberous sclerosis complex is associated with a novel human tauopathy. Acta Neuropathol 145(1):1\u201312","journal-title":"Acta Neuropathol"},{"key":"2330_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms252212335","volume":"25","author":"K Tangavelou","year":"2024","unstructured":"Tangavelou K, Bhaskar K (2024) The mechanistic link between Tau-driven proteotoxic stress and cellular senescence in Alzheimer\u2019s disease. Int J Mol Sci 25:22","journal-title":"Int J Mol Sci"},{"key":"2330_CR88","doi-asserted-by":"publisher","first-page":"1094351","DOI":"10.3389\/fphar.2022.1094351","volume":"13","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Tamilanban T, Alsayari A, Ramachawolran G, Wong LS, Sekar M et al (2022) Trilateral association of autophagy, mTOR and Alzheimer\u2019s disease: potential pathway in the development for Alzheimer\u2019s disease therapy. Front Pharmacol 13:1094351","journal-title":"Front Pharmacol"},{"key":"2330_CR89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2013.06.002","volume":"106\u2013107","author":"A Salminen","year":"2013","unstructured":"Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H et al (2013) Impaired autophagy and APP processing in Alzheimer\u2019s disease: the potential role of Beclin 1 interactome. Prog Neurobiol 106\u2013107:33\u201354","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2330_CR90","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41386-024-01994-0","volume":"50","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhao D, Zhou Y, Kong W, Xie Z, Xiong Y et al (2025) Cathepsin B modulates microglial migration and phagocytosis of amyloid beta in Alzheimer\u2019s disease through PI3K-Akt signaling. Neuropsychopharmacology 50(4):640\u2013650","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"2330_CR91","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/15548627.2023.2277634","volume":"20","author":"X Tang","year":"2024","unstructured":"Tang X, Walter E, Wohleb E, Fan Y, Wang C (2024) ATG5 (autophagy related 5) in microglia controls hippocampal neurogenesis in Alzheimer disease. Autophagy 20(4):847\u2013862","journal-title":"Autophagy"},{"issue":"11","key":"2330_CR92","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1080\/15548627.2024.2368335","volume":"20","author":"H Grosso Jasutkar","year":"2024","unstructured":"Grosso Jasutkar H, Wasserlein EM, Ishola A, Litt N, Staniszewski A, Arancio O et al (2024) Adult-onset deactivation of autophagy leads to loss of synapse homeostasis and cognitive impairment, with implications for Alzheimer disease. Autophagy 20(11):2540\u20132555","journal-title":"Autophagy"},{"issue":"9","key":"2330_CR93","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1038\/s41380-023-02289-4","volume":"28","author":"L Naia","year":"2023","unstructured":"Naia L, Shimozawa M, Bereczki E, Li X, Liu J, Jiang R et al (2023) Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in app knock-in Alzheimer mouse models. Mol Psychiatry 28(9):3966\u20133981","journal-title":"Mol Psychiatry"},{"key":"2330_CR94","doi-asserted-by":"publisher","first-page":"136288","DOI":"10.1016\/j.neulet.2021.136288","volume":"765","author":"H Choudhry","year":"2021","unstructured":"Choudhry H, Aggarwal M, Pan PY (2021) Mini-review: synaptojanin 1 and its implications in membrane trafficking. Neurosci Lett 765:136288","journal-title":"Neurosci Lett"},{"issue":"1","key":"2330_CR95","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY (2019) Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun 7(1):183","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2330_CR96","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/s41467-018-04389-0","volume":"9","author":"Q Yu","year":"2018","unstructured":"Yu Q, Wang Y, Du F, Yan S, Hu G, Origlia N et al (2018) Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer\u2019s disease. Nat Commun 9(1):2968","journal-title":"Nat Commun"},{"issue":"11","key":"2330_CR97","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.ajpath.2025.05.020","volume":"195","author":"A Djurovic-Topalovic","year":"2025","unstructured":"Djurovic-Topalovic A, Horgan NG, Fortin JS (2025) Updates on Tau-related drug targets and potential disease-modifying therapies for Alzheimer\u2019s disease. Am J Pathol 195(11):1975\u20131987","journal-title":"Am J Pathol"},{"issue":"2","key":"2330_CR98","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuron.2020.10.005","volume":"109","author":"M Kuijpers","year":"2021","unstructured":"Kuijpers M, Kochlamazashvili G, Stumpf A, Puchkov D, Swaminathan A, Lucht MT et al (2021) Neuronal autophagy regulates presynaptic neurotransmission by controlling the axonal endoplasmic reticulum. Neuron 109(2):299\u2013313 e9","journal-title":"Neuron"},{"key":"2330_CR99","doi-asserted-by":"publisher","first-page":"101191","DOI":"10.1016\/j.arr.2020.101191","volume":"64","author":"JA Pradeepkiran","year":"2020","unstructured":"Pradeepkiran JA, Reddy PH (2020) Defective mitophagy in Alzheimer\u2019s disease. Ageing Res Rev 64:101191","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2330_CR100","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40035-022-00305-1","volume":"11","author":"K Zeng","year":"2022","unstructured":"Zeng K, Yu X, Mahaman YAR, Wang JZ, Liu R, Li Y et al (2022) Defective mitophagy and the etiopathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 11(1):32","journal-title":"Transl Neurodegener"},{"issue":"5","key":"2330_CR101","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11064-020-03007-0","volume":"45","author":"Y Yan","year":"2020","unstructured":"Yan Y, Yang H, Xie Y, Ding Y, Kong D, Yu H (2020) Research progress on Alzheimer\u2019s disease and resveratrol. Neurochem Res 45(5):989\u20131006","journal-title":"Neurochem Res"},{"issue":"1","key":"2330_CR102","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12974-023-02944-1","volume":"20","author":"J Park","year":"2023","unstructured":"Park J, Kim DY, Hwang GS, Han IO (2023) Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway\/O-GlcNAc cycling and aggravates Alzheimer\u2019s disease neuropathology in adult zebrafish. J Neuroinflammation 20(1):257","journal-title":"J Neuroinflammation"},{"issue":"8081","key":"2330_CR103","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","volume":"645","author":"L Aron","year":"2025","unstructured":"Aron L, Ngian ZK, Qiu C, Choi J, Liang M, Drake DM et al (2025) Lithium deficiency and the onset of Alzheimer\u2019s disease. Nature 645(8081):712\u2013721","journal-title":"Nature"},{"key":"2330_CR104","doi-asserted-by":"crossref","unstructured":"Damri O, Shemesh N, Agam G (2020) Is there justification to treat neurodegenerative disorders by repurposing drugs? The case of Alzheimer\u2019s disease, lithium, and autophagy. Int J Mol Sci. 22(1)","DOI":"10.3390\/ijms22010189"},{"key":"2330_CR105","doi-asserted-by":"publisher","first-page":"801","DOI":"10.12659\/MSM.898679","volume":"23","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang L, Wang R, Gao Y, Che H, Pan Y et al (2017) Evaluating the effectiveness of GTM-1, rapamycin, and carbamazepine on autophagy and Alzheimer disease. Med Sci Monit 23:801\u2013808","journal-title":"Med Sci Monit"},{"issue":"1","key":"2330_CR106","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12974-023-02802-0","volume":"20","author":"M Stevenson","year":"2023","unstructured":"Stevenson M, Varghese R, Hebron ML, Liu X, Ratliff N, Smith A et al (2023) Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer\u2019s disease. J Neuroinflammation 20(1):116","journal-title":"J Neuroinflammation"},{"key":"2330_CR107","doi-asserted-by":"crossref","unstructured":"Ege D (2021) Action mechanisms of curcumin in Alzheimer\u2019s disease and its brain targeted delivery. Mater (Basel). 14(12)","DOI":"10.3390\/ma14123332"},{"issue":"2","key":"2330_CR108","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/hmg\/ddae154","volume":"34","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang S, Li Y, Zhang Y (2025) The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer\u2019s disease. Hum Mol Genet 34(2):117\u2013127","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2330_CR109","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JAD-190562","volume":"72","author":"Y Wan","year":"2019","unstructured":"Wan Y, Liang Y, Liang F, Shen N, Shinozuka K, Yu JT et al (2019) A curcumin analog reduces levels of the Alzheimer\u2019s disease-associated Amyloid-beta protein by modulating AbetaPP processing and autophagy. J Alzheimers Dis 72(3):761\u2013771","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"2330_CR110","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T et al (2021) Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell 12(10):769\u2013787","journal-title":"Protein Cell"},{"key":"2330_CR111","doi-asserted-by":"publisher","first-page":"5010741","DOI":"10.1155\/2018\/5010741","volume":"2018","author":"JG Cordero","year":"2018","unstructured":"Cordero JG, Garcia-Escudero R, Avila J, Gargini R, Garcia-Escudero V (2018) Benefit of oleuropein aglycone for Alzheimer\u2019s disease by promoting autophagy. Oxid Med Cell Longev 2018:5010741","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2330_CR112","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12974-022-02534-7","volume":"19","author":"K Freitag","year":"2022","unstructured":"Freitag K, Sterczyk N, Wendlinger S, Obermayer B, Schulz J, Farztdinov V et al (2022) Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer\u2019s disease mouse model. J Neuroinflammation 19(1):172","journal-title":"J Neuroinflammation"},{"key":"2330_CR113","doi-asserted-by":"publisher","first-page":"173406","DOI":"10.1016\/j.pbb.2022.173406","volume":"217","author":"AB Pupyshev","year":"2022","unstructured":"Pupyshev AB, Belichenko VM, Tenditnik MV, Bashirzade AA, Dubrovina NI, Ovsyukova MV et al (2022) Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer\u2019s disease-like pathology in a mouse model. Pharmacol Biochem Behav 217:173406","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"2330_CR114","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1089\/rej.2021.0062","volume":"24","author":"JW Larrick","year":"2021","unstructured":"Larrick JW, Mendelsohn AR (2021) Modulation of cGAS-STING pathway by nicotinamide riboside in Alzheimer\u2019s disease. Rejuvenation Res 24(5):397\u2013402","journal-title":"Rejuvenation Res"},{"issue":"1","key":"2330_CR115","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12943-025-02445-0","volume":"24","author":"Z Jing","year":"2025","unstructured":"Jing Z, Huang W, Mei J, Bhushan S, Wu X, Yan C et al (2025) Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis. Mol Cancer 24(1):224","journal-title":"Mol Cancer"},{"issue":"1","key":"2330_CR116","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40364-024-00593-x","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Ma B, Yang Y, Wang B, Hao J, Zhou X (2024) Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions. Biomark Res 12(1):45","journal-title":"Biomark Res"},{"key":"2330_CR117","doi-asserted-by":"publisher","first-page":"1236490","DOI":"10.3389\/fnagi.2023.1236490","volume":"15","author":"S Ma","year":"2023","unstructured":"Ma S, Wang D, Xie D (2023) Identification of disulfidptosis-related genes and subgroups in Alzheimer\u2019s disease. Front Aging Neurosci 15:1236490","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"2330_CR118","doi-asserted-by":"publisher","first-page":"e1037","DOI":"10.1002\/iid3.1037","volume":"11","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Kong L, Han T, Yan Q, Liu J (2023) Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer\u2019s disease molecular subtypes. Immun Inflamm Dis 11(10):e1037","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"2330_CR119","doi-asserted-by":"publisher","first-page":"20185","DOI":"10.1038\/s41598-024-70893-7","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang L, Li Z, Lv Y, Zhang X, Li Y, Li Y et al (2024) Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer\u2019s disease. Sci Rep 14(1):20185","journal-title":"Sci Rep"},{"issue":"7","key":"2330_CR120","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/d41573-025-00090-2","volume":"24","author":"S Crunkhorn","year":"2025","unstructured":"Crunkhorn S (2025) Triggering ferroptosis in drug-tolerant cancer cells. Nat Rev Drug Discovery 24(7):501","journal-title":"Nat Rev Drug Discovery"},{"key":"2330_CR121","doi-asserted-by":"crossref","unstructured":"Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J (2023) Iron and targeted iron therapy in Alzheimer\u2019s disease. Int J Mol Sci. 24(22)","DOI":"10.3390\/ijms242216353"},{"key":"2330_CR122","doi-asserted-by":"crossref","unstructured":"Khan MA (2025) Iron-mediated overexpression of amyloid precursor protein via iron responsive mRNA in Alzheimer\u2019s disease. Int J Mol Sci. 26(11)","DOI":"10.3390\/ijms26115283"},{"issue":"6","key":"2330_CR123","doi-asserted-by":"publisher","first-page":"e70086","DOI":"10.1111\/jnc.70086","volume":"169","author":"V Lau","year":"2025","unstructured":"Lau V, VanderZwaag J, Murray CJ, Tremblay ME (2025) Exploring iron deposition patterns using light and electron microscopy in the mouse brain across aging and Alzheimer\u2019s disease pathology conditions. J Neurochem 169(6):e70086","journal-title":"J Neurochem"},{"issue":"s1","key":"2330_CR124","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.3233\/JAD-240605","volume":"100","author":"PK Mandal","year":"2024","unstructured":"Mandal PK, Maroon JC, Samkaria A, Arora Y, Sharma S, Pandey A (2024) Iron chelators and Alzheimer\u2019s disease clinical trials. J Alzheimers Dis 100(s1):S243\u2013S9","journal-title":"J Alzheimers Dis"},{"issue":"Pt 3","key":"2330_CR125","doi-asserted-by":"publisher","first-page":"146231","DOI":"10.1016\/j.ijbiomac.2025.146231","volume":"321","author":"MA Khan","year":"2025","unstructured":"Khan MA, Mohammad T, Alalami ZS, Hassan MI (2025) Iron activates Alzheimer\u2019s amyloid precursor protein synthesis through an iron responsive element (IRE) mRNA binding to translation initiation factor. Int J Biol Macromol 321(Pt 3):146231","journal-title":"Int J Biol Macromol"},{"key":"2330_CR126","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.nbd.2024.106539","volume":"197","author":"F Casanova","year":"2024","unstructured":"Casanova F, Tian Q, Williamson DS, Qian Y, Zweibaum D, Ding J et al (2024) MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson\u2019s disease: observational and genetic analysis in the UK Biobank cohort. Neurobiol Dis 197:106539","journal-title":"Neurobiol Dis"},{"issue":"10","key":"2330_CR127","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-024-07152-0","volume":"15","author":"N Majernikova","year":"2024","unstructured":"Majernikova N, Marmolejo-Garza A, Salinas CS, Luu MDA, Zhang Y, Trombetta-Lima M et al (2024) The link between amyloid beta and ferroptosis pathway in Alzheimer\u2019s disease progression. Cell Death Dis 15(10):782","journal-title":"Cell Death Dis"},{"key":"2330_CR128","doi-asserted-by":"publisher","first-page":"103119","DOI":"10.1016\/j.redox.2024.103119","volume":"71","author":"D Padhi","year":"2024","unstructured":"Padhi D, Baruah P, Ramesh M, Moorthy H, Govindaraju T (2024) Hybrid molecules synergistically mitigate ferroptosis and amyloid-associated toxicities in Alzheimer\u2019s disease. Redox Biol 71:103119","journal-title":"Redox Biol"},{"key":"2330_CR129","doi-asserted-by":"crossref","unstructured":"Khan MA (2024) Targeting iron responsive elements (IREs) of APP mRNA into novel therapeutics to control the translation of Amyloid-beta precursor protein in Alzheimer\u2019s disease. Pharmaceuticals (Basel). 17(12)","DOI":"10.3390\/ph17121669"},{"issue":"1","key":"2330_CR130","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40001-024-01677-y","volume":"29","author":"T Kang","year":"2024","unstructured":"Kang T, Han Z, Zhu L, Cao B (2024) TFR1 knockdown alleviates iron overload and mitochondrial dysfunction during neural differentiation of Alzheimer\u2019s disease-derived induced pluripotent stem cells by interacting with GSK3B. Eur J Med Res 29(1):101","journal-title":"Eur J Med Res"},{"key":"2330_CR131","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1074\/jbc.REV120.008207","volume":"296","author":"P Lei","year":"2021","unstructured":"Lei P, Ayton S, Bush AI (2021) The essential elements of Alzheimer\u2019s disease. J Biol Chem 296:100105","journal-title":"J Biol Chem"},{"key":"2330_CR132","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin YL, Liu XZ, Shen P, Zheng YG, Lan XR et al (2020) Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 9:10","journal-title":"Transl Neurodegener"},{"key":"2330_CR133","doi-asserted-by":"publisher","first-page":"107404","DOI":"10.1016\/j.phrs.2024.107404","volume":"209","author":"YG Fan","year":"2024","unstructured":"Fan YG, Ge RL, Ren H, Jia RJ, Wu TY, Lei XF et al (2024) Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP\/PS1 transgenic mice. Pharmacol Res 209:107404","journal-title":"Pharmacol Res"},{"issue":"1","key":"2330_CR134","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2023.12.001","volume":"57","author":"A Millet","year":"2024","unstructured":"Millet A, Ledo JH, Tavazoie SF (2024) An exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer\u2019s brains. Immunity 57(1):153\u2013170 e6","journal-title":"Immunity"},{"key":"2330_CR135","doi-asserted-by":"crossref","unstructured":"Kwan P, Ho A, Baum L (2022) Effects of deferasirox in Alzheimer\u2019s disease and tauopathy animal models. Biomolecules. 12(3)","DOI":"10.3390\/biom12030365"},{"issue":"30","key":"2330_CR136","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2174\/0113816128263992231012113847","volume":"29","author":"R Thakur","year":"2023","unstructured":"Thakur R, Karwasra R, Umar T (2023) Understanding Alzheimer\u2019s disease and its metal chelation therapeutics: a narrative review. Curr Pharm Des 29(30):2377\u20132386","journal-title":"Curr Pharm Des"},{"key":"2330_CR137","doi-asserted-by":"crossref","unstructured":"Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK (2019) Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules. 10(1)","DOI":"10.3390\/biom10010059"},{"key":"2330_CR138","doi-asserted-by":"publisher","first-page":"156724","DOI":"10.1016\/j.phymed.2025.156724","volume":"141","author":"T Cao","year":"2025","unstructured":"Cao T, Liao P, Lu J, Liang G, Wei Q, Song W et al (2025) Single-nucleus RNA sequencing and network pharmacology reveal the mediation of fisetin on neuroinflammation in Alzheimer\u2019s disease. Phytomedicine 141:156724","journal-title":"Phytomedicine"},{"issue":"3","key":"2330_CR139","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s12035-024-04443-7","volume":"62","author":"Y Xu","year":"2025","unstructured":"Xu Y, Liu Y, Wu Y, Sun J, Lu X, Dai K et al (2025) Curcumin alleviates microglia-mediated neuroinflammation and neuronal ferroptosis following experimental subarachnoid hemorrhage by modulating the Nrf2\/HO-1 Signaling pathway. Mol Neurobiol 62(3):2995\u20133010","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2330_CR140","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13020-022-00634-3","volume":"17","author":"S Yang","year":"2022","unstructured":"Yang S, Xie Z, Pei T, Zeng Y, Xiong Q, Wei H et al (2022) Salidroside attenuates neuronal ferroptosis by activating the Nrf2\/HO1 signaling pathway in Abeta(1\u201342)-induced Alzheimer\u2019s disease mice and glutamate-injured HT22 cells. Chin Med 17(1):82","journal-title":"Chin Med"},{"issue":"4","key":"2330_CR141","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1620\/tjem.2024.J141","volume":"265","author":"X Zheng","year":"2025","unstructured":"Zheng X, Gong T, Yu W, Xu S, Tang C, Zhong Y et al (2025) Study on cellular mechanism of improving inflammatory effect of gastrodin. Tohoku J Exp Med 265(4):249\u2013259","journal-title":"Tohoku J Exp Med"},{"key":"2330_CR142","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","volume":"12","author":"WS Hambright","year":"2017","unstructured":"Hambright WS, Fonseca RS, Chen L, Na R, Ran Q (2017) Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol 12:8\u201317","journal-title":"Redox Biol"},{"key":"2330_CR143","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","volume":"14","author":"YH Zhang","year":"2018","unstructured":"Zhang YH, Wang DW, Xu SF, Zhang S, Fan YG, Yang YY et al (2018) Alpha-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice. Redox Biol 14:535\u2013548","journal-title":"Redox Biol"},{"key":"2330_CR144","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F et al (2023) Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther 244:108373","journal-title":"Pharmacol Ther"},{"key":"2330_CR145","doi-asserted-by":"publisher","first-page":"122359","DOI":"10.1016\/j.biomaterials.2023.122359","volume":"302","author":"J Wang","year":"2023","unstructured":"Wang J, Wang Z, Li Y, Hou Y, Yin C, Yang E et al (2023) Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer\u2019s disease. Biomaterials 302:122359","journal-title":"Biomaterials"},{"issue":"1","key":"2330_CR146","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B et al (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 15(1):174","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2330_CR147","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10534-025-00712-7","volume":"38","author":"A Deepika, Thakur","year":"2025","unstructured":"Deepika, Thakur A, Panghal A, Pundir R, Singh C, Goyal M et al (2025) Crosstalk between copper, Alzheimer\u2019s disease, and melatonin. Biometals 38(5):1381\u20131420","journal-title":"Biometals"},{"issue":"1","key":"2330_CR148","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-025-00504-6","volume":"14","author":"M Okafor","year":"2025","unstructured":"Okafor M, Faller P, Vitale N (2025) Cell-specific copper dyshomeostasis mechanism in Alzheimer\u2019s disease. Transl Neurodegener 14(1):42","journal-title":"Transl Neurodegener"},{"issue":"11","key":"2330_CR149","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.4103\/NRR.NRR-D-24-00642","volume":"20","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li D, Xu K, Wang G, Zhang F (2025) Copper homeostasis and neurodegenerative diseases. Neural Regen Res 20(11):3124\u20133143","journal-title":"Neural Regen Res"},{"issue":"11","key":"2330_CR150","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41419-024-07206-3","volume":"15","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Song M, Ren J, Liang L, Mao G, Chen M (2024) Copper homeostasis and cuproptosis in central nervous system diseases. Cell Death Dis 15(11):850","journal-title":"Cell Death Dis"},{"issue":"1","key":"2330_CR151","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-024-02071-0","volume":"10","author":"L Chen","year":"2025","unstructured":"Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X et al (2025) Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases. Signal Transduct Target Ther 10(1):31","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2330_CR152","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F (2022) Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 7(1):378","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2330_CR153","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","volume":"15","author":"X An","year":"2024","unstructured":"An X, Yu W, Liu J, Tang D, Yang L, Chen X (2024) Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis 15(8):556","journal-title":"Cell Death Dis"},{"key":"2330_CR154","doi-asserted-by":"publisher","first-page":"149173","DOI":"10.1016\/j.brainres.2024.149173","volume":"1845","author":"F Zhong","year":"2024","unstructured":"Zhong F, Xiong L, Wu J, Chen Y, Song J, Yu W et al (2024) The KEAP1\/PGAM5\/AIFM1-mediated oxeiptosis pathway in Alzheimer\u2019s disease. Brain Res 1845:149173","journal-title":"Brain Res"},{"key":"2330_CR155","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.pmbts.2025.06.014","volume":"217","author":"MT Quang","year":"2025","unstructured":"Quang MT, Nguyen MN, Than VT (2025) The role and regulation of cell death in cancer. Prog Mol Biol Transl Sci 217:135\u2013161","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2330_CR156","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K (2022) ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol 13:1039241","journal-title":"Front Immunol"},{"key":"2330_CR157","doi-asserted-by":"publisher","first-page":"149861","DOI":"10.1016\/j.brainres.2025.149861","volume":"1865","author":"Y Wang","year":"2025","unstructured":"Wang Y, Mu D, Li Y, Liu C, Feng J, Lai Y et al (2025) Alzheimer\u2019s disease: a jigsaw puzzle comprised of different types of programmed cell death pieces. Brain Res 1865:149861","journal-title":"Brain Res"},{"key":"2330_CR158","first-page":"1","volume":"353","author":"H Park","year":"2020","unstructured":"Park H, Kam TI, Dawson TM, Dawson VL (2020) Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases. Int Rev Cell Mol Biol 353:1\u201329","journal-title":"Int Rev Cell Mol Biol"},{"key":"2330_CR159","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.bcp.2024.116174","volume":"228","author":"L Yang","year":"2024","unstructured":"Yang L, Guttman L, Dawson VL, Dawson TM (2024) Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem Pharmacol 228:116174","journal-title":"Biochem Pharmacol"},{"key":"2330_CR160","doi-asserted-by":"publisher","first-page":"116045","DOI":"10.1016\/j.bcp.2024.116045","volume":"221","author":"IM Bastos","year":"2024","unstructured":"Bastos IM, Rebelo S, Silva VLM (2024) A review of poly(ADP-ribose)polymerase-1 (PARP1) role and its inhibitors bearing pyrazole or indazole core for cancer therapy. Biochem Pharmacol 221:116045","journal-title":"Biochem Pharmacol"},{"key":"2330_CR161","doi-asserted-by":"crossref","unstructured":"Maggiore A, Casale AM, Toscanelli W, Cappucci U, Rotili D, Grieco M et al (2022) Neuroprotective effects of PARP inhibitors in drosophila models of Alzheimer\u2019s disease. Cells. 11(8)","DOI":"10.3390\/cells11081284"},{"key":"2330_CR162","doi-asserted-by":"publisher","first-page":"577977","DOI":"10.1016\/j.jneuroim.2022.577977","volume":"373","author":"C Sanfilippo","year":"2022","unstructured":"Sanfilippo C, Castrogiovanni P, Imbesi R, Musumeci G, Vecchio M, Li Volti G et al (2022) Sex-dependent neuro-deconvolution analysis of Alzheimer\u2019s disease brain transcriptomes according to CHI3L1 expression levels. J Neuroimmunol 373:577977","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2330_CR163","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10571-022-01253-0","volume":"43","author":"R Cinar","year":"2023","unstructured":"Cinar R, Naziroglu M (2023) TRPM2 channel inhibition attenuates amyloid beta42-induced apoptosis and oxidative stress in the hippocampus of mice. Cell Mol Neurobiol 43(3):1335\u20131353","journal-title":"Cell Mol Neurobiol"},{"key":"2330_CR164","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2017.03.027","volume":"647","author":"Z Yao","year":"2017","unstructured":"Yao Z, Yang W, Gao Z, Jia P (2017) Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease. Neurosci Lett 647:133\u2013140","journal-title":"Neurosci Lett"},{"issue":"2","key":"2330_CR165","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41422-024-01037-9","volume":"35","author":"HB Shim","year":"2025","unstructured":"Shim HB, Deniset JF, Kubes P (2025) Knowing when to stop: MICL self-regulates neutrophil NETosis. Cell Res 35(2):89\u201390","journal-title":"Cell Res"},{"key":"2330_CR166","doi-asserted-by":"publisher","first-page":"118568","DOI":"10.1016\/j.biopha.2025.118568","volume":"192","author":"S Chavoshinezhad","year":"2025","unstructured":"Chavoshinezhad S, Beirami E, Izadpanah E (2025) Neutrophils and NETosis in Alzheimer\u2019s disease: unraveling pathogenic mechanisms and novel therapeutic targets. Biomed Pharmacother 192:118568","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2330_CR167","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-022-01347-2","volume":"10","author":"LCD Smyth","year":"2022","unstructured":"Smyth LCD, Murray HC, Hill M, van Leeuwen E, Highet B, Magon NJ et al (2022) Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer\u2019s disease. Acta Neuropathol Commun 10(1):38","journal-title":"Acta Neuropathol Commun"},{"key":"2330_CR168","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2017.00211","volume":"8","author":"EC Pietronigro","year":"2017","unstructured":"Pietronigro EC, Della Bianca V, Zenaro E, Constantin G (2017) NETosis in Alzheimer\u2019s disease. Front Immunol 8:211","journal-title":"Front Immunol"},{"key":"2330_CR169","doi-asserted-by":"publisher","first-page":"114666","DOI":"10.1016\/j.intimp.2025.114666","volume":"155","author":"C Tang","year":"2025","unstructured":"Tang C, Wang J, Ge M, Fu L, Huang J, Yadav H et al (2025) DSS-induced colitis exacerbates Alzheimer\u2019s pathology via neutrophil elastase and cathepsin B activation. Int Immunopharmacol 155:114666","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2330_CR170","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","volume":"46","author":"M Pszczolowska","year":"2024","unstructured":"Pszczolowska M, Walczak K, Miskow W, Mroziak M, Chojdak-Lukasiewicz J, Leszek J (2024) Mitochondrial disorders leading to Alzheimer\u2019s disease-perspectives of diagnosis and treatment. Geroscience 46(3):2977\u20132988","journal-title":"Geroscience"},{"issue":"18","key":"2330_CR171","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acschemneuro.4c00205","volume":"15","author":"T Retinasamy","year":"2024","unstructured":"Retinasamy T, Lee ALY, Lee HS, Lee VLL, Shaikh MF, Yeong KY (2024) Repurposing anakinra for Alzheimer\u2019s disease: the in vitro and in vivo effects of anakinra on LPS- and AC-induced neuroinflammation. ACS Chem Neurosci 15(18):3298\u20133310","journal-title":"ACS Chem Neurosci"},{"key":"2330_CR172","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.arr.2025.102711","volume":"106","author":"B Jia","year":"2025","unstructured":"Jia B, Xu Y, Zhu X (2025) Cognitive resilience in Alzheimer\u2019s disease: mechanism and potential clinical intervention. Ageing Res Rev 106:102711","journal-title":"Ageing Res Rev"},{"key":"2330_CR173","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms25189947","volume":"25","author":"D Guo","year":"2024","unstructured":"Guo D, Liu Z, Zhou J, Ke C, Li D (2024) Significance of programmed cell death pathways in neurodegenerative diseases. Int J Mol Sci 25:18","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"2330_CR174","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10495-024-02041-5","volume":"30","author":"L Cai","year":"2025","unstructured":"Cai L, Fan Q, Pang R, Chen C, Zhang Y, Xie H et al (2025) Microglia programmed cell death in neurodegenerative diseases and CNS injury. Apoptosis 30(1\u20132):446\u2013465","journal-title":"Apoptosis"},{"issue":"1","key":"2330_CR175","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00401-024-02722-0","volume":"147","author":"DR Thal","year":"2024","unstructured":"Thal DR, Gawor K, Moonen S (2024) Regulated cell death and its role in Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Acta Neuropathol 147(1):69","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2330_CR176","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","volume":"112","author":"C Lopez-Lee","year":"2024","unstructured":"Lopez-Lee C, Torres ERS, Carling G, Gan L (2024) Mechanisms of sex differences in Alzheimer\u2019s disease. Neuron 112(8):1208\u20131221","journal-title":"Neuron"},{"key":"2330_CR177","doi-asserted-by":"crossref","unstructured":"Monaco M, Torazza C, Fedele E, Grilli M (2025) The impact of the exposome on Alzheimer\u2019s disease: the influence of nutrition. Int J Mol Sci 26(7)","DOI":"10.3390\/ijms26073015"},{"issue":"3","key":"2330_CR178","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s11357-023-00782-w","volume":"45","author":"MM Sonsalla","year":"2023","unstructured":"Sonsalla MM, Lamming DW (2023) Geroprotective interventions in the 3xTg mouse model of Alzheimer\u2019s disease. Geroscience 45(3):1343\u20131381","journal-title":"Geroscience"},{"issue":"1","key":"2330_CR179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","volume":"82","author":"S Ayton","year":"2025","unstructured":"Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P et al (2025) Deferiprone in Alzheimer disease: a randomized clinical trial. JAMA Neurol 82(1):11\u201318","journal-title":"JAMA Neurol"},{"key":"2330_CR180","doi-asserted-by":"publisher","first-page":"1464858","DOI":"10.3389\/fimmu.2024.1464858","volume":"15","author":"Y Meng","year":"2024","unstructured":"Meng Y, Zhang Q, Xu M, Ding K, Yu Z, Li J (2024) Pyroptosis regulation by Salmonella effectors. Front Immunol 15:1464858","journal-title":"Front Immunol"},{"issue":"7\u20138","key":"2330_CR181","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","volume":"27","author":"S Kari","year":"2022","unstructured":"Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M (2022) Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis 27(7\u20138):482\u2013508","journal-title":"Apoptosis"},{"issue":"4","key":"2330_CR182","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","volume":"34","author":"X Liu","year":"2024","unstructured":"Liu X, Zhuang L, Gan B (2024) Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol 34(4):327\u2013337","journal-title":"Trends Cell Biol"},{"issue":"17","key":"2330_CR183","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.1073\/pnas.2002571117","volume":"117","author":"AR Rezai","year":"2020","unstructured":"Rezai AR, Ranjan M, D\u2019Haese PF, Haut MW, Carpenter J, Najib U et al (2020) Noninvasive hippocampal blood-brain barrier opening in Alzheimer\u2019s disease with focused ultrasound. Proc Natl Acad Sci U S A 117(17):9180\u20139182","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6750","key":"2330_CR184","doi-asserted-by":"publisher","first-page":"eady3217","DOI":"10.1126\/science.ady3217","volume":"388","author":"E Topol","year":"2025","unstructured":"Topol E (2025) Predicting and preventing Alzheimer\u2019s disease. Science 388(6750):eady3217","journal-title":"Science"},{"issue":"39","key":"2330_CR185","doi-asserted-by":"publisher","first-page":"e2201401","DOI":"10.1002\/smll.202201401","volume":"18","author":"S Kawakita","year":"2022","unstructured":"Kawakita S, Mandal K, Mou L, Mecwan MM, Zhu Y, Li S et al (2022) Organ-On-A-Chip models of the blood-brain barrier: recent advances and future prospects. Small 18(39):e2201401","journal-title":"Small"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02330-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:04:06Z","timestamp":1777633446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02330-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":185,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2330"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02330-1","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have consented to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"115"}}